Skip to main content

17.02.2018 | Original Article | Ausgabe 4/2018

Comparative Clinical Pathology 4/2018

Amelioration of renal structural changes in STZ-induced diabetic mice with ethanolic extract of Allium saralicum R.M. Fritsch

Comparative Clinical Pathology > Ausgabe 4/2018
Mohammad Mahdi Zangeneh, Nader Goodarzi, Akram Zangeneh, Reza Tahvilian, Fariba Najafi


The purpose of this study was to assess the hypoglycemic and protective activities of the ethanolic extract of Allium saralicum (AS) in streptozotocin (STZ) induced diabetic mice. Diabetes was experimentally induced by intraperitoneal injection of STZ (60 mg/kg bw) in 35 mice. Fasting blood glucose (FBG) levels were measured everyday using glucometer strips. Mice with plasma glucose level > 250 mg/dL were considered diabetic. After 3 days, they were divided randomly into five groups. Groups 1 and 2 served as non-diabetic and untreated diabetic controls, respectively. Group 3 received 0.5 mg/kg glibenclamide orally. Groups 4 and 5 were given 200 and 400 μg/kg, respectively, of AS for 15 days orally. At 16th day, the animals were dissected and their kidney removed. The total volume of cortex, medulla, renal tubules, and glomeruli as well as the length of vessels and renal tubules was estimated using stereological method. Daily treatment of diabetic mice with high dose of AS significantly (p ≤ 0.05) declined FBG levels at days 10–13 of the experiment faster than glibenclamide. High dose of AS could significantly (p ≤ 0.05) improve the volume of cortex, glomeruli, proximal tubules, distal tubules, vessels, and total length of proximal tubules and vessels. Moreover, glomerular loss was significantly (p ≤ 0.05) inhibited with high dose of AS. It concluded that Allium saralicum could improve hyperglycemia and ameliorated renal changes following diabetes in STZ-induced diabetic mice. So, according to these features, it could be used as an antidiabetic supplement.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Über diesen Artikel

Weitere Artikel der Ausgabe 4/2018

Comparative Clinical Pathology 4/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie

01.10.2020 | Magenkarzinom | Schwerpunkt: In-situ-Hybridisierung | Ausgabe 6/2020

ISH-basierte HER2-Diagnostik

30.09.2020 | Schwerpunkt: In-situ-Hybridisierung | Ausgabe 6/2020

RNA-in-situ-Hybridisierung: Technologie, Möglichkeiten und Anwendungsbereiche

28.09.2020 | Lungenkarzinome | Schwerpunkt: In-situ-Hybridisierung | Ausgabe 6/2020

Anwendungen der FISH in der Diagnostik von Lungenkarzinomen